DYN logo

Dyne Therapeutics (DYN) Cash from financing

annual CFF:

$809.89M+$755.57M(+1390.92%)
December 31, 2024

Summary

  • As of today (May 29, 2025), DYN annual cash flow from financing activities is $809.89 million, with the most recent change of +$755.57 million (+1390.92%) on December 31, 2024.
  • During the last 3 years, DYN annual CFF has risen by +$652.07 million (+413.17%).
  • DYN annual CFF is now at all-time high.

Performance

DYN Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

quarterly CFF:

$141.24M+$137.60M(+3784.52%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN quarterly cash flow from financing activities is $141.24 million, with the most recent change of +$137.60 million (+3784.52%) on March 31, 2025.
  • Over the past year, DYN quarterly CFF has dropped by -$267.15 million (-65.41%).
  • DYN quarterly CFF is now -65.41% below its all-time high of $408.39 million, reached on March 31, 2024.

Performance

DYN quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

TTM CFF:

$542.75M-$267.15M(-32.99%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN TTM cash flow from financing activities is $542.75 million, with the most recent change of -$267.15 million (-32.99%) on March 31, 2025.
  • Over the past year, DYN TTM CFF has increased by +$108.85 million (+25.09%).
  • DYN TTM CFF is now -32.99% below its all-time high of $809.89 million, reached on December 31, 2024.

Performance

DYN TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

DYN Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1390.9%-65.4%+25.1%
3 y3 years+413.2%+10000.0%+10000.0%
5 y5 years+3951.7%+1086.1%+4457.8%

DYN Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+2066.1%-65.4%>+9999.0%-33.0%>+9999.0%
5 y5-yearat high+3951.7%-65.4%+1361.8%-33.0%>+9999.0%
alltimeall timeat high+6419.8%-65.4%+1361.8%-33.0%>+9999.0%

DYN Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$141.24M(+3784.5%)
$542.75M(-33.0%)
Dec 2024
$809.89M(+1390.9%)
$3.64M(-79.8%)
$809.89M(+0.4%)
Sep 2024
-
$18.01M(-95.3%)
$806.41M(+2.2%)
Jun 2024
-
$379.86M(-7.0%)
$788.85M(+81.8%)
Mar 2024
-
$408.39M(>+9900.0%)
$433.89M(+698.7%)
Dec 2023
$54.32M(+45.3%)
$147.00K(-67.6%)
$54.32M(-40.6%)
Sep 2023
-
$454.00K(-98.2%)
$91.38M(+0.4%)
Jun 2023
-
$24.91M(-13.6%)
$90.99M(+37.5%)
Mar 2023
-
$28.82M(-22.5%)
$66.19M(+77.0%)
Dec 2022
$37.39M
$37.20M(>+9900.0%)
$37.39M(>+9900.0%)
Sep 2022
-
$70.00K(-29.3%)
$276.00K(-58.4%)
DateAnnualQuarterlyTTM
Jun 2022
-
$99.00K(+450.0%)
$663.00K(+12.6%)
Mar 2022
-
$18.00K(-79.8%)
$589.00K(-99.6%)
Dec 2021
$157.82M(-58.5%)
$89.00K(-80.5%)
$157.82M(+7.7%)
Sep 2021
-
$457.00K(+1728.0%)
$146.54M(-72.1%)
Jun 2021
-
$25.00K(-100.0%)
$526.06M(+0.0%)
Mar 2021
-
$157.25M(-1504.8%)
$526.03M(+38.2%)
Dec 2020
$380.69M(+1804.5%)
-$11.19M(-102.9%)
$380.69M(-2.9%)
Sep 2020
-
$379.98M(>+9900.0%)
$391.88M(+3190.9%)
Jun 2020
-
$0.00(-100.0%)
$11.91M(0.0%)
Mar 2020
-
$11.91M
$11.91M
Dec 2019
$19.99M(+60.9%)
-
-
Dec 2018
$12.42M
-
-

FAQ

  • What is Dyne Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Dyne Therapeutics?
  • What is Dyne Therapeutics annual CFF year-on-year change?
  • What is Dyne Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Dyne Therapeutics?
  • What is Dyne Therapeutics quarterly CFF year-on-year change?
  • What is Dyne Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Dyne Therapeutics?
  • What is Dyne Therapeutics TTM CFF year-on-year change?

What is Dyne Therapeutics annual cash flow from financing activities?

The current annual CFF of DYN is $809.89M

What is the all time high annual CFF for Dyne Therapeutics?

Dyne Therapeutics all-time high annual cash flow from financing activities is $809.89M

What is Dyne Therapeutics annual CFF year-on-year change?

Over the past year, DYN annual cash flow from financing activities has changed by +$755.57M (+1390.92%)

What is Dyne Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of DYN is $141.24M

What is the all time high quarterly CFF for Dyne Therapeutics?

Dyne Therapeutics all-time high quarterly cash flow from financing activities is $408.39M

What is Dyne Therapeutics quarterly CFF year-on-year change?

Over the past year, DYN quarterly cash flow from financing activities has changed by -$267.15M (-65.41%)

What is Dyne Therapeutics TTM cash flow from financing activities?

The current TTM CFF of DYN is $542.75M

What is the all time high TTM CFF for Dyne Therapeutics?

Dyne Therapeutics all-time high TTM cash flow from financing activities is $809.89M

What is Dyne Therapeutics TTM CFF year-on-year change?

Over the past year, DYN TTM cash flow from financing activities has changed by +$108.85M (+25.09%)
On this page